Latest:
Dr. Ciccolini on Dose Levels of Cetuximab in Head and Neck Cancer
Joseph Ciccolini, PhD, assistant professor in Pharmocokinetics, Aix-Marseille University, discusses dose levels of cetuximab (Erbitux) in patients with head and neck cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Joseph F. Renzulli, II, MD, FACS
Latest:
Dr. Renzulli on Expanded Access Program With Radium-223
Joseph F. Renzulli, II, MD, FACS, assistant professor of surgery (urology) clinical, Alpert Medical School, discusses the expanded access program in the United States for radium-223 dichloride in patients with metastatic castration-resistant prostate cancer.
Joseph Jurcic, MD
Latest:
Dr. Jurcic on Lintuzumab and Low-Dose Cytarabine for AML
Joseph Jurcic, MD, professor of Clinical Medicine, director of the Hematologic Malignancies Section of the Hematology/Oncology Division, Columbia University Medical Center, discusses a phase I trial of lintuzumab and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML).
Joseph Uberti, MD, PhD
Latest:
Dr. Uberti on Transplant in Myelodysplastic Syndrome
Joseph Uberti, MD, PhD, division head, BMT, Leukemia & Lymphoma, professor of medicine, Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, discusses the use of transplant in myelodysplastic syndrome (MDS).
Josephine Feliciano, MD
Latest:
The Importance of Mentorship for Oncology and Hematology Fellows
What is mentorship? The term "mentor" originates with the mythological character Mentor, with whom Odysseus entrusted his son, Telemachus. Mentor was responsible for educating and instilling values in Telemachus when Odysseus departed for the Trojan War.
Josephine Lai, PharmD, MBA, BCPS, & Ted Wun, MD
Latest:
Oncology Pharmacy Program Ensures Medication Adherence
The rise of oral anticancer agents is revolutionizing cancer treatment for both patients and cancer care providers. Patients can take their medications in the comfort of their own homes without the need for needles, long stints in infusion chairs or intensive nursing oversight.